期刊文献+

缓释VEGF的可吸收性微管在TMR中的应用研究 被引量:1

Applied study of biodegradable capsules containing VEGF in TMR
下载PDF
导出
摘要 目的 :观察血管内皮细胞生长因子结合缓释技术 ,促机械性TMR管道内血管生成的作用。方法 :利用机械钻在家兔左室前壁进行心肌钻孔 ,形成透室壁性心肌管道 ,实验组心肌管道内放入含VEGF及肝素的可吸收性多孔缓释微管 ;对照组放入不含VEGF及肝素的可吸收性多孔缓释微管。动物于术后8周处死 ,利用组织切片染色法 ,对照观察实验组和对照组TMR管道内血管生成状况。结果 :实验组TMR管道内血管生成的密度 /数量为 9.2 4± 0 .46条 /10× 4倍 ;对照组为 1.98± 0 .87条 /10× 4倍 ,两者具有非常显著性差异 ,P <0 .0 0 1。结论 :VEGF通过可吸收性多孔微管的缓释作用 ,对管道内血管的再生与重建具有非常明显的促进作用。 Objective: To research the effect of vascular endothelial growth factor (VEGF) with controlled drug release system on the angiogenesis and revascularization in the drilling TMR channels from the view of morphology. Methods: Transmyocardial channels were made by machine drilling in vivo on left ventricular wall of the rabbits. In the experimental group, the biodegradable capsules containing VEGF were put in the channels after TMR; while in control group, the capsules put in channels didn't contain VEGF .The animals in two groups were sacrificed at 8 weeks after TMR . The effect of angiogenesis and revascularization were observed, and the new vessels(NV) in channels of two groups were measured under microscope. Results: Statistical analysis demonstrated a high significant difference between the experimental and control groups in the density and quantity of new vessels(9.24±0.46NV per 10×4 field in experimental group versus 1.98±0.87 NV per 10×4 in control group, P <0.001).Conclusion: The results confirm that the good effect of angiogenesis and revascularization in the drilling channels can be received by the stimulation of VEGF through control drug release system.
出处 《中国临床解剖学杂志》 CSCD 北大核心 2003年第3期247-249,共3页 Chinese Journal of Clinical Anatomy
基金 国家自然科学基金资助项目 (39870 385)
关键词 血管内皮细胞生长因子 缓释 机械钻孔 透室壁性心肌血管重建术 血管生成 VEGF controlled drug release system drilling TMR angiogenesis
  • 相关文献

参考文献9

二级参考文献17

  • 1施化莲,1990年
  • 2Yie W,1982年
  • 3Malekan R, Reynolds C, Narula N, et al. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury[J]. Circulation, 1998, 98 (19 suppl): II62~65.
  • 4Engler DA. Use of vascular endothelial growth factor for therapeutic angiogenesis[J]. Circulation, 1996,94(7): 1496~1498.
  • 5Lery AP, Levy NS, Wegner S, et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia[J]. J Biol Chem, 1995, 270: 13333~13340.
  • 6Debabrata M, Leonidas T, Zhou XM, et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation[J]. Nature, 1995, 375(6532): 577~581.
  • 7Ferrara N, Houck K, Jakeman L, et al. The vascular endothelial growth factor family of polypeptides[J]. J Cell Biochem, 1991, 47(3): 211~218.
  • 8Mark CA, Magovern CJ, Hahn RT, et al. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser; Results and comparisons to nonlased channels[J]. Circulation, 1997, 96 (9 suppl.): II 65~69.
  • 9Fisher SE, Frame JW, Browne RM, et al. A comparative histologic study of wound healing following CO2 laser and conventional surgical excision of canine buccal mucosa[J]. Arch Oral Biol, 1983, 28(4):287~291.
  • 10曾际斌.血管内皮生长因子研究进展[J].国外医学(分子生物学分册),2000,22(2):87-92. 被引量:10

共引文献16

同被引文献33

  • 1陈扬,肖建德,李振宇,闫洪印,罗新乐,全大萍,卢泽俭.血管内皮生长因子缓释微粒的合成与制备[J].中国骨肿瘤骨病,2004,3(3):150-151. 被引量:3
  • 2朱艳,鲁莹,钟延强.生物降解聚合物支架在组织工程学中的制备和应用[J].中国药学杂志,2005,40(13):961-964. 被引量:7
  • 3FERRARA N, HENZEL W J. Pituitay follicalar cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells [J]. Biochem Biophys Res Commam,1989,16(2) :851-858.
  • 4KEYT B A, BERLEAU L T, NGUYEN H V, et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency [J]. Biol Chem,1996, 271:7788-7795.
  • 5FERRARA N, ALITALO K( Clinical applications of angiogenic growth factors and their inhibitors [J]. Nature Med,1999, 5(12):1359-1364.
  • 6TAKESHITA S, ZHENG L P, BROGI E, et al. Therapeatic anglogenesis. A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in rabbit ischemic hind limb model [J]. Clin Invest,1994, 93: 662-670.
  • 7PEARLMAN J D,HIBBERD M G,CHUANG M L, et al . Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis[J]. Nature Med,1995 ,1:1(K5-1089.
  • 8CHENXJ GUORQ.Research progress of vascular endothelial growth factor in coronary heart disease therapy .武汉大学研究生学报:医学版,2004,20(2):125-128.
  • 9CLELAND J L, DUENAS E T, PARK A, et al. Development of poly(D, L-Lactide-co-glycolide) microspheres formtdation containing recombinant human vascular endothelial growth factor to promote local angiogenesis [J]. J Controlled Release,2001,72:13-24.
  • 10ARRAS M, MOLLNAU H, STRASSER R, et al. The delivery of angiogenic factors to heart by microsphere therapy [J]. Nat Biotechnol, 1998,16:159-162.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部